Review
Copyright ©The Author(s) 2023.
World J Gastroenterol. Nov 14, 2023; 29(42): 5699-5715
Published online Nov 14, 2023. doi: 10.3748/wjg.v29.i42.5699
Table 1 Typical studies on tumor-associated exosomes that affect esophageal cancer progression
Molecules in exosomes
Biological process
Targets
Ref.
lncRNA ZFAS1Regulate proliferation, invasion, migration, and apoptosisMicroRNA-124, STAT3[2]
miR-103a-2-5pPromote proliferation and migration of ESCC cells-[3]
miR-93-5pPromote the proliferation of esophageal cancer cellsPTEN, p21, CCND1[4]
miR-200aPromote the proliferation, migration, and invasion of esophageal cells and inhibits apoptosisKEAP1, NRF2[5]
miR-19b-3pInhibit apoptosis, promote cell migration and invasionPTEN[6]
LINC01410Promote metastasis and epithelial-mesenchymal transitionmiR-122-5p, PKM2[7]
lncRNA FAM225AAccelerate progression and angiogenesismiR-206, NETO2, FOXP1[8]
miRNA-21-5pPromote angiogenesis and malignant progression-[9]
miR-154-5pAttenuate progression and angiogenesisKIF14[10]
miR-301a-3pPromote angiogenesisPTEN[11]
uc.189Promote proliferation and lymph angiogenesis of human lymphatic endothelial cells and thus facilitate lymph node metastasisEPHA2[12]
Table 2 Clinical application of exosome in esophageal cancer
Clinical application
Biofluids
Exosomes or exosomal cargos
Expression
Ref.
DiagnosisPlasmamiR-106a, miR-18a, miR-20b, miR-486-5p, miR-584 High[155]
SerumlncRNA UCA1, POU3F3, ESCCAL-1 and PEG10High[156]
PlasmalncRNAs NR_039819, NR_036133, NR_003353, ENST00000442416.1, and ENST00000416100.1High[157]
PlasmamiR-223-3pLow[122]
PrognosisSerummiR-182High[158]
SerummiR-766-3pHigh[159]
Serumhsa_circ_0026611High[160]
SerumlncRNA-POU3F3High[156]
Plasmahsa_circ_0001946Low[161]